BioSpace News Archive

RadioMedix Inc. is pleased to announce that the company has been selected for the 2019-2020 Commercialization Accelerator Program by the National Institute of Health SBIR/STTR program office.

Atrium Innovations, a Nestlé Health Science company, to leverage clinician-designed, algorithm-driven platform with healthcare providers

Economic activity in the manufacturing sector contracted in December, and the overall economy grew for the 128th consecutive month, say the nation’s supply executives in the latest Manufacturing ISM® Report On Business®.

Thermo Fisher Scientific and Agilent Technologies today announced they are continuing their agreement to the industry-wide Instrument Control Exchange Program (ICEP) – fostering compatibility among key vendors’ instrumentation and chromatography data systems (CDS)

LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that JJ Pellegrino, Chief Financial Officer, will present at the 22nd Annual Needham Growth Conference on Wednesday, January 15, 2020

Akebia Therapeutics, Inc., a biopharmaceutical company focused on the development and commercialization of therapeutics for people living with kidney disease, granted six newly-hired employees options to purchase an aggregate of 113,450 shares of Akebia’s common stock on December 31, 2019, as inducements material to each such employee’s entering into employment with Akebia.

Quest Diagnostics Incorporated (NYSE: DGX), the world’s leading provider of diagnostic information services, announced that it is scheduled to speak at the 38th Annual J. P. Morgan Healthcare Conference in San Francisco.

Organigram Holdings Inc. announced it will report earnings results for its first quarter fiscal 2020 ended November 30, 2019 on Tuesday, January 14th after market close.